• The AIRNA Team
  • Board of Directors
  • Founders
  • Investors

A team that is passionate about restoring patient health.

Arch Ventures
FTI
+ND Capital
Novalis
Beatrice Darimont
VP Biology and Preclinical
Devyn Smith
Arbor Bio
Thorsten Stafforst
Founder
Christopher Volkert
Research Associate
Eric Moessinger
ND Capital
Jin Billy Li
Founder
Daniella Mizurini
Senior Scientist
Gabriela Ecco
ND Capital (Observer)
Keith L. Crandell
ARCH Venture Partners (Observer)
Dirk Lindenblatt
Scientist
“RNA editing has unique potential to make transformative medicines for many patients”
Rodger Novak
Elisangela Bressan
Senior Scientist
Eva-Maria Duerr
Scientist
Inga Jarmoskaite
Senior Scientist
Juri Eyberg
Scientist
One Airna
Konstantin Licht
Senior Scientist
Kris Elverum
President and CEO
“RNA editing opens a world of possibilities never seen before”
Thorsten Stafforst, Founder
Kris Elverum
President and CEO
Reetika Bhardwaj
ARCH Venture Partners (Observer)
Lena Fischer
Sr. Director Finance & Operations
Rodger Novak
Entrepreneur
Sean Kendall
ARCH Venture Partners
Li-Hao Chang
Scientist
Luise Stafforst
Lab manager
Thorsten Stafforst
Founder
Paul Vogel
VP Research & Managing Director
Paul Vogel
VP Research & Managing Director
Piotr Putaj
Principal Scientist
Rewati Tappu
Senior Scientist
Sriram Sathy
CSO
Sruthi V. Hindupur
Scientist
Tobias Merkle
Senior Director, Platform Development
Tobias Merkle
Senior Director, Platform Development
Veronica Giachin
Research Associate

TRANSFORMING LIVES,
ONE TEAMMATE AT A TIME

Working at AIRNA

TRANSFORMING LIVES,
ONE EXPERIMENT AT A TIME

Go to science

TRANSFORMING LIVES,
ONE AIRNA AT A TIME

Go to science